Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?

A. Gidron, Amit K. Verma, M. Doyle, L. Boggio, A. Evens, L. Gordon, S. Singhal, M. Tallman, S. Wlliams, J. Winter, J. Mehta

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

A total of 415 leukaphereses in 201 patients stimulated with growth factor (GF; n = 119) or chemotherapy-GF (n = 296) were studied to determine CD34 + cell collection efficiency (CE). The pre-apheresis leukocyte count was 1-93 × 109/l (median 20), and peripheral blood CD34 count (PBCD34) was 1-1104/μl (median 19). The total number of CD34+ cells collected was 4-6531 × 106 (median 151); corresponding to 0.1-111.4 × 106 (median 2.3) per kg. There was strong correlation between PBCD34 and the number of CD34+ cells collected (r = 0.9; P < 0.0001). CE was 7-145% (median 46). On multiple regression analysis, a higher leukocyte count (P < 0.0001) was the most important predictor of lower CE. CE with leukocytes < 20 was 7-145% (median 53%) compared to 10-132% (median 40%) with leukocyte ≥ 20 (P < 0.0001). In all, 61% of the apheresis procedures performed after chemotherapy-GF occurred when leukocytes were < 20 compared to 21% of those performed after GF alone (P < 0.0001). We conclude that mobilizing patients with the combination of chemotherapy and GF rather than GF alone leads to leukapheresis being performed when the leukocyte count is low - in a range that results in optimum CD34+ cell CE. Autologous stem cells should be mobilized with chemotherapy-GF rather than GF alone whenever possible.

Original languageEnglish (US)
Pages (from-to)243-246
Number of pages4
JournalBone Marrow Transplantation
Volume35
Issue number3
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Mobilization
Leukapheresis
Hematologic Neoplasms
Leukocyte Count
Blood Component Removal
Leukocytes
Drug Therapy
Cell Count
Combination Drug Therapy
Intercellular Signaling Peptides and Proteins
Stem Cells
Regression Analysis

Keywords

  • CD34+ cells
  • Cell separator
  • Collection efficiency
  • Leukapheresis

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? / Gidron, A.; Verma, Amit K.; Doyle, M.; Boggio, L.; Evens, A.; Gordon, L.; Singhal, S.; Tallman, M.; Wlliams, S.; Winter, J.; Mehta, J.

In: Bone Marrow Transplantation, Vol. 35, No. 3, 02.2005, p. 243-246.

Research output: Contribution to journalArticle

Gidron, A. ; Verma, Amit K. ; Doyle, M. ; Boggio, L. ; Evens, A. ; Gordon, L. ; Singhal, S. ; Tallman, M. ; Wlliams, S. ; Winter, J. ; Mehta, J. / Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?. In: Bone Marrow Transplantation. 2005 ; Vol. 35, No. 3. pp. 243-246.
@article{d385b15b5f6740a6a7bd395d02e62dc5,
title = "Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?",
abstract = "A total of 415 leukaphereses in 201 patients stimulated with growth factor (GF; n = 119) or chemotherapy-GF (n = 296) were studied to determine CD34 + cell collection efficiency (CE). The pre-apheresis leukocyte count was 1-93 × 109/l (median 20), and peripheral blood CD34 count (PBCD34) was 1-1104/μl (median 19). The total number of CD34+ cells collected was 4-6531 × 106 (median 151); corresponding to 0.1-111.4 × 106 (median 2.3) per kg. There was strong correlation between PBCD34 and the number of CD34+ cells collected (r = 0.9; P < 0.0001). CE was 7-145{\%} (median 46). On multiple regression analysis, a higher leukocyte count (P < 0.0001) was the most important predictor of lower CE. CE with leukocytes < 20 was 7-145{\%} (median 53{\%}) compared to 10-132{\%} (median 40{\%}) with leukocyte ≥ 20 (P < 0.0001). In all, 61{\%} of the apheresis procedures performed after chemotherapy-GF occurred when leukocytes were < 20 compared to 21{\%} of those performed after GF alone (P < 0.0001). We conclude that mobilizing patients with the combination of chemotherapy and GF rather than GF alone leads to leukapheresis being performed when the leukocyte count is low - in a range that results in optimum CD34+ cell CE. Autologous stem cells should be mobilized with chemotherapy-GF rather than GF alone whenever possible.",
keywords = "CD34+ cells, Cell separator, Collection efficiency, Leukapheresis",
author = "A. Gidron and Verma, {Amit K.} and M. Doyle and L. Boggio and A. Evens and L. Gordon and S. Singhal and M. Tallman and S. Wlliams and J. Winter and J. Mehta",
year = "2005",
month = "2",
doi = "10.1038/sj.bmt.1704781",
language = "English (US)",
volume = "35",
pages = "243--246",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?

AU - Gidron, A.

AU - Verma, Amit K.

AU - Doyle, M.

AU - Boggio, L.

AU - Evens, A.

AU - Gordon, L.

AU - Singhal, S.

AU - Tallman, M.

AU - Wlliams, S.

AU - Winter, J.

AU - Mehta, J.

PY - 2005/2

Y1 - 2005/2

N2 - A total of 415 leukaphereses in 201 patients stimulated with growth factor (GF; n = 119) or chemotherapy-GF (n = 296) were studied to determine CD34 + cell collection efficiency (CE). The pre-apheresis leukocyte count was 1-93 × 109/l (median 20), and peripheral blood CD34 count (PBCD34) was 1-1104/μl (median 19). The total number of CD34+ cells collected was 4-6531 × 106 (median 151); corresponding to 0.1-111.4 × 106 (median 2.3) per kg. There was strong correlation between PBCD34 and the number of CD34+ cells collected (r = 0.9; P < 0.0001). CE was 7-145% (median 46). On multiple regression analysis, a higher leukocyte count (P < 0.0001) was the most important predictor of lower CE. CE with leukocytes < 20 was 7-145% (median 53%) compared to 10-132% (median 40%) with leukocyte ≥ 20 (P < 0.0001). In all, 61% of the apheresis procedures performed after chemotherapy-GF occurred when leukocytes were < 20 compared to 21% of those performed after GF alone (P < 0.0001). We conclude that mobilizing patients with the combination of chemotherapy and GF rather than GF alone leads to leukapheresis being performed when the leukocyte count is low - in a range that results in optimum CD34+ cell CE. Autologous stem cells should be mobilized with chemotherapy-GF rather than GF alone whenever possible.

AB - A total of 415 leukaphereses in 201 patients stimulated with growth factor (GF; n = 119) or chemotherapy-GF (n = 296) were studied to determine CD34 + cell collection efficiency (CE). The pre-apheresis leukocyte count was 1-93 × 109/l (median 20), and peripheral blood CD34 count (PBCD34) was 1-1104/μl (median 19). The total number of CD34+ cells collected was 4-6531 × 106 (median 151); corresponding to 0.1-111.4 × 106 (median 2.3) per kg. There was strong correlation between PBCD34 and the number of CD34+ cells collected (r = 0.9; P < 0.0001). CE was 7-145% (median 46). On multiple regression analysis, a higher leukocyte count (P < 0.0001) was the most important predictor of lower CE. CE with leukocytes < 20 was 7-145% (median 53%) compared to 10-132% (median 40%) with leukocyte ≥ 20 (P < 0.0001). In all, 61% of the apheresis procedures performed after chemotherapy-GF occurred when leukocytes were < 20 compared to 21% of those performed after GF alone (P < 0.0001). We conclude that mobilizing patients with the combination of chemotherapy and GF rather than GF alone leads to leukapheresis being performed when the leukocyte count is low - in a range that results in optimum CD34+ cell CE. Autologous stem cells should be mobilized with chemotherapy-GF rather than GF alone whenever possible.

KW - CD34+ cells

KW - Cell separator

KW - Collection efficiency

KW - Leukapheresis

UR - http://www.scopus.com/inward/record.url?scp=13944279952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944279952&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1704781

DO - 10.1038/sj.bmt.1704781

M3 - Article

C2 - 15580281

AN - SCOPUS:13944279952

VL - 35

SP - 243

EP - 246

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -